Navigation Links
Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency
Date:6/30/2009

PORTON DOWN, England, June 30 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory).

BVD is considered to be one of the main threats to cattle (1), affecting the majority of herds in the UK. It is closely related to classical swine fever virus, a serious disease of pigs, and to border disease virus, which infects sheep.

The Enigma FL instrument was used to analyse more than 100 blood samples that had already been screened by antigen ELISA and a laboratory-based RT-PCR for the presence of the BVD virus. Approximately half of the samples were proved BVDV positive by the laboratory-based PCR. With the level of concordance between the two tests being above 97%, this confirmed the Enigma FL system can produce laboratory-standard results with a high degree of confidence.

The Enigma FL has been designed for easy operation. Tests are provided in a single-use cartridge that can be stored at room temperature. The Enigma FL provides a PCR result in less than one hour, a timescale needed to allow field-based & pen-side diagnosis. On-site testing removes delays from transport of samples to the laboratory, which can often take days. The system requires minimal training and its utility for "pen-side" testing for BVD has already been demonstrated.(2)

John McKinley, Chairman and CEO of Enigma, stated: "The Enigma Diagnostics tests could be deployed for the related viral diseases, such as classical swine fever, with minor modifications. The system itself is broadly applicable to many other veterinary pathogens, such as TB in cattle, bacterial infections and other viral infections, such as foot and mouth disease and avian influenza. Allowing vets to use advanced m
'/>"/>

SOURCE Enigma Diagnostics Limited
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
2. Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
3. Enigma Signs Real-Time PCR Licences With Applera
4. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
5. Enigma Diagnostics Announces Patent Licence With Applied Biosystems
6. Enigma Diagnostics Announces the Opening of a United States Office
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Strategic Diagnostics Updates Roth Conference Presentation Time
9. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
10. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
11. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...s available in German . , Whether it,s CD p... tags (Radio Frequency Identification) are increas...ake it possible to label objects or goods and iden...propriate scanner can read and process the data co...to goods under production conditions of up to 100 ...
(Date:11/24/2009)... The New York investment bank KTA Capital,...agreed an AU$6.7 mil convertible note private plac...ate placement was arranged by KTA Capital as Neure... New York (PRWEB) November 23, ...TA Capital, LLC ("KTA Capital") has anno...
(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...sreceivednoticefrom,theNasdaqStockMarketthattradin...mber30,2009andaForm25-NSEwillbefiledwiththe,Securi...ommonstock,fromlistingonNasdaq,unlessthecompanyfil...hecompanyhasfiledsuchanappeal,which,willstaythesus...
(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...valofallofits,"firstday"motionsbytheU.S.Bankruptcy...").deCODElastweekfiledavoluntarypetitionfor,relief...he,BankruptcyCourt. , TheordersissuedbytheBan...businessduringtheChapter11proceedings.Inparticular...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...S CLINICALS AND DRUG DEVELOPMENT, ROCKVILLE, Md.,...: CUR ) announced that Dr. Thomas Hazel will be,r...Research. He will be,working with Dr. Karl Johe, N... manage the company,s upcoming clinical trial for ... disease), and complete,development of Neuralstem,...
... Advance Clinical Development Of Lead Drug Candida...ma today announced the,closing of a CDN $45 millio...ew investor, Mitsubishi Tanabe Pharma Corporation ...vestors including Vengrowth Advanced Life,Sciences..., Novo A/S,Canadian Medical Discoveries Fund Inc.,...
...ck Exchange Symbol: MS, EDMONTON, July 30 /PRNews...leading developer in the treatment of multiple scl... President and CEO, will present at the BMO,Capita...York., WHEN: Wednesday August 6th at 8:30am (Ea..., New York About BioMS Medical Corp., BioMS Medi...
Other Biology Technology:Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3BioMS Medical to present at BMO Healthcare Conference 2
(Date:11/24/2009)...kable class of ring-shaped protein motors has been...ey National Laboratory (Berkeley Lab) using a stat...he Advanced Light Source (ALS). These protein moto...cation, and are vital to the survival of all biolo... the human papillomavirus, which has been linked t...
(Date:11/24/2009)... held secrets of the earth,s history locked in its...ry little information on the environments that hav... years. Now, a team of researchers from nine insti...ne of $10 million dollars by the National Science ... literally. These scientists will drill through t...
(Date:11/24/2009)...nish . , The presence of increased body fat,...ances in the blood, hinders the loss and maintenan...of the University of Navarra conducted by Estbaliz...rmacy. , The project, entitled "A nutrigenetic a...f body weight and inflammation," examines how the ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 1Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 3Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 4Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 5Famous Names Get Single Neurons Fired Up 52757 1Famous Names Get Single Neurons Fired Up 52757 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 1PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 3PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 4
... Magnetic Snakes Create Water Current , M. Belkin...al Review Letters (forthcoming) , Physicists at A...c particles suspended in water and subjected to an... structures that can control the flow of the surro... snake are a few centimeters long, but the team en...
...A dinosaur skeleton found 24 years ago in Montana ... links North American,dinosaurs with Asian dinosau...s, walked on two feet and stood about three feet t... million years old , A paper on the finding was p...rtebrate Paleontology, co-author Jack Horner said ...
...ger Expected to Strengthen Position in Enterprise ...ology Portfolio with Established and Growing ...D, Wash., and AUSTIN, Texas, Sept. 4 ,Saflink Corp...ider of,solutions designed to verify identity, sec...I, Inc., a privately held provider of enterprise,s...
Other Biology News:Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 2Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 3New dinosaur species found in Montana 2Saflink and IdentiPHI Announce Merger Agreement 2Saflink and IdentiPHI Announce Merger Agreement 3Saflink and IdentiPHI Announce Merger Agreement 4Saflink and IdentiPHI Announce Merger Agreement 5
... flexibility of the BDTM LSR, the first UV benchto... II. The BD LSR II has performance, capabilities,...nalyzer. Free up your high-performance cell sorte...laser to the BD LSR II. The BD LSR II can be confi...
... apparatus is used to screen blots of mini format ... different antibodies or sera without having to cu...ase plate, 2 separate, detachable sample templates...nd gaskets and clamps that secure the blots to for...
SlideHyb Glass Array Hybridization Buffer #2 from Ambion
DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
Biology Products: